Safety, Tolerability and Efficacy Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test if the investigational medication ABT-089 is a safe and
effective treatment for adults with Attention-Deficit/Hyperactivity Disorder (ADHD).